Table 2. Demographic characteristics of the total vaccinated cohort.
| |
Form 1 n = 78 |
Form 1/2 n = 78 |
Form 1/3 n = 78 |
Control n = 78 |
|
|---|---|---|---|---|---|
| Characteristic | Categories | Value/n (%) | Value/n (%) | Value/n (%) | Value/n (%) |
| Age (in months) |
Mean |
17.4 |
18.0 |
17.7 |
17.5 |
| |
SD |
3.81 |
2.96 |
3.38 |
3.59 |
| |
Range |
12–24 |
12–23 |
12–23 |
12–23 |
| Gender |
Female |
37 (47.4) |
31 (39.7) |
35 (44.9) |
40 (51.3) |
| |
Male |
41 (52.6) |
47 (60.3) |
43 (55.1) |
38 (48.7) |
| Geographic ancestry | South East Asian | 78 (100) | 78 (100) | 78 (100) | 78 (100) |
Form 1 received DTPw-HBV-IPV (full dose)/Hib vaccine; Form 1/2 received DTPw-HBV-IPV (1/2 dose)/Hib vaccine; Form 1/3 received DTPw-HBV-IPV (1/3 dose)/Hib vaccine; controls received DTPw-HBV/Hib Kft and IPV vaccines concomitantly; N, total number of subjects; value/n, value of considered parameter/number of subjects in a given category; SD, standard deviation.